FDA recall record

Mylan Institutional Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 recall — FDA D-1112-2018

Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer

Class IIIclassification
D-1112-2018official record ID
Aug 29, 2018report date

Recall record at a glance

Official recordD-1112-2018
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmMylan Institutional, Inc. (d.b.a. UDL Laboratories)
Report dateAug 29, 2018
Recall initiation dateAug 14, 2018
Quantity408 cartons
LocationRockford, IL, United States

Official product description

Diltiazem HCl Extended-release Capsules, USP 120 mg, 80 capsules, 8 blister cards of 10 capsules each per carton, Rx Only, Manufactured by: Mylan Pharmaceuticals Inc., Morgantown, WV. NDC 51079-947-08

Why the product was recalled

Failed Impurities/Degradation Specifications; out of specification results for related compound per the manufacturer

Distribution information

Nationwide USA

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.